rs2294984

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001853.4(COL9A3):​c.50G>A​(p.Gly17Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.145 in 1,399,514 control chromosomes in the GnomAD database, including 15,911 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G17R) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.13 ( 1315 hom., cov: 33)
Exomes 𝑓: 0.15 ( 14596 hom. )

Consequence

COL9A3
NM_001853.4 missense

Scores

1
1
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 0.421

Publications

9 publications found
Variant links:
Genes affected
COL9A3 (HGNC:2219): (collagen type IX alpha 3 chain) This gene encodes one of the three alpha chains of type IX collagen, the major collagen component of hyaline cartilage. Type IX collagen, a heterotrimeric molecule, is usually found in tissues containing type II collagen, a fibrillar collagen. Mutations in this gene are associated with multiple epiphyseal dysplasia type 3. [provided by RefSeq, Jan 2010]
COL9A3 Gene-Disease associations (from GenCC):
  • epiphyseal dysplasia, multiple, 3
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Illumina, G2P, Labcorp Genetics (formerly Invitae)
  • Stickler syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Ambry Genetics, Genomics England PanelApp, ClinGen
  • Stickler syndrome, type 6
    Inheritance: AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • multiple epiphyseal dysplasia due to collagen 9 anomaly
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive Stickler syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0021308362).
BP6
Variant 20-62817114-G-A is Benign according to our data. Variant chr20-62817114-G-A is described in ClinVar as Benign. ClinVar VariationId is 193218.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.154 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL9A3NM_001853.4 linkc.50G>A p.Gly17Glu missense_variant Exon 1 of 32 ENST00000649368.1 NP_001844.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL9A3ENST00000649368.1 linkc.50G>A p.Gly17Glu missense_variant Exon 1 of 32 NM_001853.4 ENSP00000496793.1
COL9A3ENST00000477612.5 linkn.75-453G>A intron_variant Intron 1 of 11 3

Frequencies

GnomAD3 genomes
AF:
0.126
AC:
19055
AN:
151338
Hom.:
1314
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0994
Gnomad AMI
AF:
0.0746
Gnomad AMR
AF:
0.0977
Gnomad ASJ
AF:
0.103
Gnomad EAS
AF:
0.0346
Gnomad SAS
AF:
0.0700
Gnomad FIN
AF:
0.161
Gnomad MID
AF:
0.111
Gnomad NFE
AF:
0.156
Gnomad OTH
AF:
0.123
GnomAD2 exomes
AF:
0.105
AC:
7842
AN:
74786
AF XY:
0.106
show subpopulations
Gnomad AFR exome
AF:
0.0977
Gnomad AMR exome
AF:
0.0555
Gnomad ASJ exome
AF:
0.0988
Gnomad EAS exome
AF:
0.0366
Gnomad FIN exome
AF:
0.153
Gnomad NFE exome
AF:
0.152
Gnomad OTH exome
AF:
0.121
GnomAD4 exome
AF:
0.148
AC:
184420
AN:
1248068
Hom.:
14596
Cov.:
31
AF XY:
0.146
AC XY:
89540
AN XY:
615008
show subpopulations
African (AFR)
AF:
0.0983
AC:
2466
AN:
25084
American (AMR)
AF:
0.0650
AC:
1576
AN:
24234
Ashkenazi Jewish (ASJ)
AF:
0.105
AC:
2149
AN:
20468
East Asian (EAS)
AF:
0.0227
AC:
563
AN:
24782
South Asian (SAS)
AF:
0.0677
AC:
4510
AN:
66604
European-Finnish (FIN)
AF:
0.154
AC:
4647
AN:
30132
Middle Eastern (MID)
AF:
0.110
AC:
388
AN:
3522
European-Non Finnish (NFE)
AF:
0.161
AC:
161688
AN:
1003328
Other (OTH)
AF:
0.129
AC:
6433
AN:
49914
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
7707
15413
23120
30826
38533
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6162
12324
18486
24648
30810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.126
AC:
19055
AN:
151446
Hom.:
1315
Cov.:
33
AF XY:
0.123
AC XY:
9118
AN XY:
74006
show subpopulations
African (AFR)
AF:
0.0993
AC:
4116
AN:
41466
American (AMR)
AF:
0.0977
AC:
1486
AN:
15204
Ashkenazi Jewish (ASJ)
AF:
0.103
AC:
357
AN:
3462
East Asian (EAS)
AF:
0.0343
AC:
177
AN:
5162
South Asian (SAS)
AF:
0.0702
AC:
339
AN:
4826
European-Finnish (FIN)
AF:
0.161
AC:
1658
AN:
10312
Middle Eastern (MID)
AF:
0.106
AC:
31
AN:
292
European-Non Finnish (NFE)
AF:
0.156
AC:
10569
AN:
67712
Other (OTH)
AF:
0.121
AC:
254
AN:
2098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
883
1766
2650
3533
4416
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
216
432
648
864
1080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.134
Hom.:
183
Bravo
AF:
0.120
TwinsUK
AF:
0.166
AC:
616
ALSPAC
AF:
0.159
AC:
611
ExAC
AF:
0.0663
AC:
4505
Asia WGS
AF:
0.0400
AC:
129
AN:
3212

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 05, 2017
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency in 1000Genomes: 272/2178=12.48% -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
Jun 05, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Epiphyseal dysplasia, multiple, 3 Benign:1
May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Connective tissue disorder Benign:1
Jul 18, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.27
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.21
CADD
Benign
13
DANN
Benign
0.92
DEOGEN2
Benign
0.0070
T;T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.26
N
LIST_S2
Benign
0.26
.;T
MetaRNN
Benign
0.0021
T;T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
1.2
L;L
PhyloP100
0.42
PrimateAI
Pathogenic
0.84
D
PROVEAN
Benign
-1.0
.;N
REVEL
Uncertain
0.35
Sift
Benign
0.28
.;T
Sift4G
Benign
0.37
.;T
Polyphen
0.079
B;B
Vest4
0.17
MPC
0.091
ClinPred
0.00070
T
GERP RS
0.41
PromoterAI
-0.089
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.086
gMVP
0.58
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2294984; hg19: chr20-61448466; COSMIC: COSV51702900; COSMIC: COSV51702900; API